Harpreet Grewal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Harpreet Grewal has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Rahul Kashyap
Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA, USA
5 shared publications Gagandeep Dhillon
University of Maryland Baltimore Washington Medical Center
4 shared publications- Gagandeep Dhillon
Department of Internal Medicine, University of Maryland Baltimore Washington Medical Center, Glen Burnie, MD 21061, USA
4 shared publications - Pranjal Sharma
Nephrology, Northeast Ohio Medical University, Rootstown, OH 44272, USA
4 shared publications Rahul Kashyap
Global Remote Research Scholars Program, Princeton Junction, NJ, USA
4 shared publications- Ram Kishun Verma
Parkview Health System, Fort Wayne, IN 46845, USA
4 shared publications
Latest Publications
- Open Access
- 21 May 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Medical Students’ Perceptions of Large Language Models in Healthcare: A Multinational Cross-Sectional Study
Background: Artificial intelligence (AI) and large language models (LLMs), are potential tools for enhancing healthcare delivery and clinical research. Presently, there is a scarcity of research regarding the viewpoints of medical students toward LLMs. This study aims to explore the perceptions of LLMs and their applications among this demographic. Methods: A cross-sectional study was done using an online survey. It was designed using Google Forms and circulated from July 2023 to August 2023. The target population included medical students from Ecuador, Ethiopia, India, Mauritius, Pakistan, United Arab Emirates (UAE), and the United States (USA). Results: A total of 1180 responses were collected from 10 medical colleges across 7 countries. The UAE had the largest number of responses (31.7%), followed by Ecuador (17.6%), and Mauritius (13.7%). And 77.4% respondents were already aware about LLMs before attempting the survey, most popularly, ChatGPT. Participants were most familiar with the specific use of LLMs in research (46%), and the lowest familiarity was seen in the use of LLMs in healthcare (37%). More than half of the participants (52%) support the use of LLMs healthcare, yet a significant number of them remained neutral (37%) or disagreed (31%) on LLMs being safe in this context. Conclusion: While most of the medical students are aware of LLMs and their applications, the multinational survey demonstrated hesitancy among medical students in fully adopting LLMs into healthcare practice and clinical research. This study prompts further exploration of medical students’ attitudes and acceptance concerning the integration of LLMs for research methodologies, ethical considerations, and healthcare practice.
- 21 May 2025
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 12
Open AccessMedical Students’ Perceptions of Large Language Models in Healthcare: A Multinational Cross-Sectional Study
Background: Artificial intelligence (AI) and large language models (LLMs), are potential tools for enhancing healthcare delivery and clinical research. Presently, there is a scarcity of research regarding the viewpoints of medical students toward LLMs. This study aims to explore the perceptions of LLMs and their applications among this demographic. Methods: A cross-sectional study was done using an online survey. It was designed using Google Forms and circulated from July 2023 to August 2023. The target population included medical students from Ecuador, Ethiopia, India, Mauritius, Pakistan, United Arab Emirates (UAE), and the United States (USA). Results: A total of 1180 responses were collected from 10 medical colleges across 7 countries. The UAE had the largest number of responses (31.7%), followed by Ecuador (17.6%), and Mauritius (13.7%). And 77.4% respondents were already aware about LLMs before attempting the survey, most popularly, ChatGPT. Participants were most familiar with the specific use of LLMs in research (46%), and the lowest familiarity was seen in the use of LLMs in healthcare (37%). More than half of the participants (52%) support the use of LLMs healthcare, yet a significant number of them remained neutral (37%) or disagreed (31%) on LLMs being safe in this context. Conclusion: While most of the medical students are aware of LLMs and their applications, the multinational survey demonstrated hesitancy among medical students in fully adopting LLMs into healthcare practice and clinical research. This study prompts further exploration of medical students’ attitudes and acceptance concerning the integration of LLMs for research methodologies, ethical considerations, and healthcare practice.
- Open Access
- 1 August 2024
- Published by MDPI AG in Endocrines
- Vol. 5  (3) , 323-333
Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects
As obesity evolves as a global pandemic, the use of drugs to treat it is booming. The latest among these are Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Along with their use, the incidence of adverse events has become more common. Although severe effects have been mentioned, details and associations are unclear regarding some of them. We performed a systematic review of studies related to GLP-1 RA drugs. Drugs that have been the subject of at least three studies meeting all our criteria were included. Analysis of GLP-1 RA therapies across eight studies, involving 4422 subjects, indicated varying rates of Serious Adverse Events (SAEs). Semaglutide demonstrated an SAE incidence of 8.9%, compared to 6.2% for Liraglutide. These results were not statistically significant. For both drugs, no clear association with pancreatitis or neoplasm was established. Discontinuation rates due to adverse effects were 10.3% for Semaglutide and 8.3% for Liraglutide. Severe adverse effects with GLP-1 RA use are not uncommon, and warrant further close monitoring when patients are started on treatment. Further studies are required to analyze the difference between the adverse effect profiles of each drug and to assess whether or not each of these severe adverse effects is dose dependent.
- 1 August 2024
- Published by MDPI AG in Endocrines
- Vol. 5  (3) , 323-333
Open AccessGlucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects
As obesity evolves as a global pandemic, the use of drugs to treat it is booming. The latest among these are Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Along with their use, the incidence of adverse events has become more common. Although severe effects have been mentioned, details and associations are unclear regarding some of them. We performed a systematic review of studies related to GLP-1 RA drugs. Drugs that have been the subject of at least three studies meeting all our criteria were included. Analysis of GLP-1 RA therapies across eight studies, involving 4422 subjects, indicated varying rates of Serious Adverse Events (SAEs). Semaglutide demonstrated an SAE incidence of 8.9%, compared to 6.2% for Liraglutide. These results were not statistically significant. For both drugs, no clear association with pancreatitis or neoplasm was established. Discontinuation rates due to adverse effects were 10.3% for Semaglutide and 8.3% for Liraglutide. Severe adverse effects with GLP-1 RA use are not uncommon, and warrant further close monitoring when patients are started on treatment. Further studies are required to analyze the difference between the adverse effect profiles of each drug and to assess whether or not each of these severe adverse effects is dose dependent.
- Open Access
- 4 April 2024
- Published by Qeios Ltd in Qeios Preprints
Viewpoint: Strategic Insights and a Scoping Review of Telehealth Platforms and SWOT Analysis of Amazon's Clinical Endeavors
The adoption of telehealth services has surged in the wake of the COVID-19 pandemic, revolutionizing traditional healthcare delivery models. Amazon Clinic's nationwide launch marks a significant milestone in this trend. We aim to offer a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis of Amazon Clinic and compare its features with leading virtual healthcare platforms. Amazon Clinic capitalizes on its vast consumer base, transparent pricing, and AI-driven intake for efficient healthcare. The competitive landscape features established healthcare providers and other telehealth platforms like CVS Minute Clinic and Teladoc, each with their unique strengths and services, creating challenges for Amazon Clinic. Strengths include easy access and a transparent pricing model, filling gaps especially for the uninsured and young adults. Weaknesses are the lack of pediatric care and potential fragmented doctor-patient relationships. Opportunities lie in democratizing healthcare and filling system gaps. Threats include navigating complex regulations and competition from well-established providers. Limitations like non-acceptance of insurance could impede broader adoption. The platform excels for minor ailments but is less suitable for complex conditions requiring sustained, personalized care. Future success depends on regulatory navigation and establishing partnerships to broaden its service offerings.
- 4 April 2024
- Published by Qeios Ltd in Qeios Preprints
Open AccessViewpoint: Strategic Insights and a Scoping Review of Telehealth Platforms and SWOT Analysis of Amazon's Clinical Endeavors
The adoption of telehealth services has surged in the wake of the COVID-19 pandemic, revolutionizing traditional healthcare delivery models. Amazon Clinic's nationwide launch marks a significant milestone in this trend. We aim to offer a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis of Amazon Clinic and compare its features with leading virtual healthcare platforms. Amazon Clinic capitalizes on its vast consumer base, transparent pricing, and AI-driven intake for efficient healthcare. The competitive landscape features established healthcare providers and other telehealth platforms like CVS Minute Clinic and Teladoc, each with their unique strengths and services, creating challenges for Amazon Clinic. Strengths include easy access and a transparent pricing model, filling gaps especially for the uninsured and young adults. Weaknesses are the lack of pediatric care and potential fragmented doctor-patient relationships. Opportunities lie in democratizing healthcare and filling system gaps. Threats include navigating complex regulations and competition from well-established providers. Limitations like non-acceptance of insurance could impede broader adoption. The platform excels for minor ailments but is less suitable for complex conditions requiring sustained, personalized care. Future success depends on regulatory navigation and establishing partnerships to broaden its service offerings.
- Open Access
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (2) , 973
Hydrogen Water: Extra Healthy or a Hoax?—A Systematic Review
Hydrogen-rich water (HRW) has emerged as a novel approach in the field of health and wellness. It is believed to have therapeutic antioxidant properties that can neutralize harmful free radicals in the human body. It has also been shown to be beneficial in mitigating oxidative stress-induced damage through its anti-inflammatory and anti-apoptotic pathways. We aim to conduct a systematic review to evaluate the potential benefits of hydrogen-rich water. The review protocol was uploaded on PROSPERO. After the initial search criteria, the articles were reviewed by two blinded investigators, and a total of 25 articles were included in the systematic review. The potential benefits of hydrogen-rich water on various aspects of health, including exercise capacity, physical endurance, liver function, cardiovascular disease, mental health, COVID-19, oxidative stress, and anti-aging research, are a subject of growing interest and ongoing research. Although preliminary results in clinical trials and studies are encouraging, further research with larger sample sizes and rigorous methodologies is needed to substantiate these findings. Current research needs to fully explain the mechanisms behind the potential benefits of hydrogen-rich water. Continued scientific exploration will provide valuable insights into the potential of hydrogen-rich water as an adjunctive therapeutic approach in the future.
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (2) , 973
Open AccessHydrogen Water: Extra Healthy or a Hoax?—A Systematic Review
Hydrogen-rich water (HRW) has emerged as a novel approach in the field of health and wellness. It is believed to have therapeutic antioxidant properties that can neutralize harmful free radicals in the human body. It has also been shown to be beneficial in mitigating oxidative stress-induced damage through its anti-inflammatory and anti-apoptotic pathways. We aim to conduct a systematic review to evaluate the potential benefits of hydrogen-rich water. The review protocol was uploaded on PROSPERO. After the initial search criteria, the articles were reviewed by two blinded investigators, and a total of 25 articles were included in the systematic review. The potential benefits of hydrogen-rich water on various aspects of health, including exercise capacity, physical endurance, liver function, cardiovascular disease, mental health, COVID-19, oxidative stress, and anti-aging research, are a subject of growing interest and ongoing research. Although preliminary results in clinical trials and studies are encouraging, further research with larger sample sizes and rigorous methodologies is needed to substantiate these findings. Current research needs to fully explain the mechanisms behind the potential benefits of hydrogen-rich water. Continued scientific exploration will provide valuable insights into the potential of hydrogen-rich water as an adjunctive therapeutic approach in the future.
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Glucagon Like Peptide-1 Receptor Agonists: Is It As Good as It Seems? A Systematic Review of Severe Adverse Effects
Introduction: As obesity evolves as a global pandemic along with diabetes mellitus, the development and use of drugs used to treat the same is booming. The latest among them is Glucagon-like peptide-1 receptor agonists (GLP-1 RA). Along with the use, the incidence of adverse events has become more common. It becomes imperative to focus on severe adverse effects for this reason. Although mentioned, there has been no detailed discussions regarding severe adverse effects and associations are also unclear regarding some. Methods: A systematic search was conducted for full length manuscripts published in the last two decades. We focused on papers that listed severe adverse effects with some details. Studies involving the pediatric population and patients on multiple oral antihyperglycemics were excluded. Statistical Analysis: Data analysis was performed using Revman 5.0 version. Results: The analysis of GLP-1RA therapies across 8 studies, involving 4422 subjects, indicates varying rates of Serious Adverse Events (SAE). Semaglutide demonstrates an SAE incidence of 8.9%, compared to 6.2% with Liraglutide, though not statistically significant. The analysis indicated Semaglutide had an elevated SAE risk with an Odds ratio (OR)=1.27, but did not have statistical significance (95% CI 0.84-1.91, p=0.26, I2=63%). Similarly, patients in the Liraglutide group had an increased risk of SAE with OR of 1.19 (95%CI 0.91-1.55, p=0.86, I2=40%) but this did not reach statistical significance. In both Semaglutide and Liraglutide, gastrointestinal adverse events predominate, with pancreatitis and neoplasm incidence noted, albeit without a clear causal relationship established. Discontinuation rates due to adverse effects were 10.3% for Semaglutide versus 3.1% for placebo, and 8.3% for Liraglutide versus 3.3% for placebo. The classification of these incidents as SAEs was unclear, and hence, they were excluded from statistical analysis. Conclusion: Severe adverse effects with GLP-1 RA are not uncommon and warrant further close monitoring when patients are started on the treatment. Further studies are required to analyze the difference between the adverse effect profiles of each drug and to assess whether or not each of the severe adverse effects is dose dependent.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessGlucagon Like Peptide-1 Receptor Agonists: Is It As Good as It Seems? A Systematic Review of Severe Adverse Effects
Introduction: As obesity evolves as a global pandemic along with diabetes mellitus, the development and use of drugs used to treat the same is booming. The latest among them is Glucagon-like peptide-1 receptor agonists (GLP-1 RA). Along with the use, the incidence of adverse events has become more common. It becomes imperative to focus on severe adverse effects for this reason. Although mentioned, there has been no detailed discussions regarding severe adverse effects and associations are also unclear regarding some. Methods: A systematic search was conducted for full length manuscripts published in the last two decades. We focused on papers that listed severe adverse effects with some details. Studies involving the pediatric population and patients on multiple oral antihyperglycemics were excluded. Statistical Analysis: Data analysis was performed using Revman 5.0 version. Results: The analysis of GLP-1RA therapies across 8 studies, involving 4422 subjects, indicates varying rates of Serious Adverse Events (SAE). Semaglutide demonstrates an SAE incidence of 8.9%, compared to 6.2% with Liraglutide, though not statistically significant. The analysis indicated Semaglutide had an elevated SAE risk with an Odds ratio (OR)=1.27, but did not have statistical significance (95% CI 0.84-1.91, p=0.26, I2=63%). Similarly, patients in the Liraglutide group had an increased risk of SAE with OR of 1.19 (95%CI 0.91-1.55, p=0.86, I2=40%) but this did not reach statistical significance. In both Semaglutide and Liraglutide, gastrointestinal adverse events predominate, with pancreatitis and neoplasm incidence noted, albeit without a clear causal relationship established. Discontinuation rates due to adverse effects were 10.3% for Semaglutide versus 3.1% for placebo, and 8.3% for Liraglutide versus 3.3% for placebo. The classification of these incidents as SAEs was unclear, and hence, they were excluded from statistical analysis. Conclusion: Severe adverse effects with GLP-1 RA are not uncommon and warrant further close monitoring when patients are started on the treatment. Further studies are required to analyze the difference between the adverse effect profiles of each drug and to assess whether or not each of the severe adverse effects is dose dependent.
- Open Access
- 30 December 2023
- Published by Springer Nature in Cureus
- Vol. 15  (12) , e51342
Teleradiology and the Compensation Conundrum in India
Teleradiology, an established telemedicine practice globally, has significantly enhanced the accessibility of high-quality radiological interpretations in remote areas worldwide, especially in India, thereby improving healthcare outcomes. The utilization of teleradiology services has seen a marked increase, expanding its reach into more distant regions of the country. However, this burgeoning field faces numerous regulatory, financial, and technical challenges. The current scenario regarding teleradiology in India is a double-edged sword. There is an increasing demand for it due to the expanding population, resulting in larger imaging volumes needing radiologist services. This editorial aims to examine the prevailing challenges in teleradiology in India, with an emphasis on the compensation model for teleradiologists, which has not kept pace with the growing demand for services and often remains inequitable.
- 30 December 2023
- Published by Springer Nature in Cureus
- Vol. 15  (12) , e51342
Open AccessTeleradiology and the Compensation Conundrum in India
Teleradiology, an established telemedicine practice globally, has significantly enhanced the accessibility of high-quality radiological interpretations in remote areas worldwide, especially in India, thereby improving healthcare outcomes. The utilization of teleradiology services has seen a marked increase, expanding its reach into more distant regions of the country. However, this burgeoning field faces numerous regulatory, financial, and technical challenges. The current scenario regarding teleradiology in India is a double-edged sword. There is an increasing demand for it due to the expanding population, resulting in larger imaging volumes needing radiologist services. This editorial aims to examine the prevailing challenges in teleradiology in India, with an emphasis on the compensation model for teleradiologists, which has not kept pace with the growing demand for services and often remains inequitable.
- Open Access
- 25 December 2023
- Published by MDPI AG in Preprints.org
Hydrogenated Water: Extra Healthy or a Hoax?: A Systematic Review
Hydrogenated water has emerged as a novel approach in the field of health and wellness. It is be-lieved to have potent antioxidant properties that can neutralize harmful free radicals in the hu-man body. It has also been shown to be beneficial in mitigating oxidative stress-induced damage through its anti-inflammatory and anti-apoptotic pathways. We aim to conduct a systematic re-view to evaluate the potential benefits of hydrogenated water. The review protocol was uploaded on PROSPERO. After the initial search criteria, the articles were reviewed by two blinded inves-tigators, and a total of 25 articles were included in the systematic review. The potential benefits of hydrogenated water on various aspects of health, including exercise capacity, physical endurance, liver function, cardiovascular disease, mental health, COVID-19, oxidative stress, and anti-aging research, are a subject of growing interest and ongoing research. Although preliminary results in clinical trials and studies are encouraging, further research with larger sample sizes and rigor-ous methodologies is needed to substantiate these findings. Current research needs to fully ex-plain the mechanisms behind the potential benefits of hydrogenated water. Continued scientific exploration will provide valuable insights into the potential of hydrogenated water as an adjunc-tive therapeutic approach in the future.
- 25 December 2023
- Published by MDPI AG in Preprints.org
Open AccessHydrogenated Water: Extra Healthy or a Hoax?: A Systematic Review
Hydrogenated water has emerged as a novel approach in the field of health and wellness. It is be-lieved to have potent antioxidant properties that can neutralize harmful free radicals in the hu-man body. It has also been shown to be beneficial in mitigating oxidative stress-induced damage through its anti-inflammatory and anti-apoptotic pathways. We aim to conduct a systematic re-view to evaluate the potential benefits of hydrogenated water. The review protocol was uploaded on PROSPERO. After the initial search criteria, the articles were reviewed by two blinded inves-tigators, and a total of 25 articles were included in the systematic review. The potential benefits of hydrogenated water on various aspects of health, including exercise capacity, physical endurance, liver function, cardiovascular disease, mental health, COVID-19, oxidative stress, and anti-aging research, are a subject of growing interest and ongoing research. Although preliminary results in clinical trials and studies are encouraging, further research with larger sample sizes and rigor-ous methodologies is needed to substantiate these findings. Current research needs to fully ex-plain the mechanisms behind the potential benefits of hydrogenated water. Continued scientific exploration will provide valuable insights into the potential of hydrogenated water as an adjunc-tive therapeutic approach in the future.
- Open Access
- 21 June 2023
- Published by Springer Nature in Cureus
- Vol. 15  (6) , e40733
Universal Health Care System in India: An In-Depth Examination of the Ayushman Bharat Initiative
This editorial provides an in-depth review of the Ayushman Bharat initiative, India's universal healthcare scheme, designed to address significant disparities in healthcare access and quality across the country. Following the structure of the healthcare system and socioeconomic trends, the manuscript assesses the reasons for the initiative's creation, its coverage, implementation strategies, role during the COVID-19 pandemic, auxiliary pilot programs, and challenges for future progress. It focuses on how the initiative has increased healthcare accessibility, financial protection, transformed the healthcare infrastructure, and provided relief during the COVID-19 crisis. Critical issues such as gaps between supply and demand, the need for increased government spending, and the challenges of access and quality in rural health centers are also discussed. We aim to raise awareness about the program's benefits among potential beneficiaries, which is a key to the initiative's success and a potential role model for equitable global healthcare.
- 21 June 2023
- Published by Springer Nature in Cureus
- Vol. 15  (6) , e40733
Open AccessUniversal Health Care System in India: An In-Depth Examination of the Ayushman Bharat Initiative
This editorial provides an in-depth review of the Ayushman Bharat initiative, India's universal healthcare scheme, designed to address significant disparities in healthcare access and quality across the country. Following the structure of the healthcare system and socioeconomic trends, the manuscript assesses the reasons for the initiative's creation, its coverage, implementation strategies, role during the COVID-19 pandemic, auxiliary pilot programs, and challenges for future progress. It focuses on how the initiative has increased healthcare accessibility, financial protection, transformed the healthcare infrastructure, and provided relief during the COVID-19 crisis. Critical issues such as gaps between supply and demand, the need for increased government spending, and the challenges of access and quality in rural health centers are also discussed. We aim to raise awareness about the program's benefits among potential beneficiaries, which is a key to the initiative's success and a potential role model for equitable global healthcare.
- Open Access
- 8 June 2023
- Published by Springer Nature in Cureus
- Vol. 15  (6) , e40135
Radiology Gets Chatty: The ChatGPT Saga Unfolds
As artificial intelligence (AI) continues to evolve and mature, it is increasingly finding applications in the field of healthcare, particularly in specialties like radiology that are data-heavy and image-focused. Language learning models (LLMs) such as OpenAI's Generative Pre-trained Transformer-4 (GPT-4) are new in the field of medicine and there is a paucity of literature regarding the possible utilities of GPT-4 given its novelty. We aim to present an in-depth exploration of the role of GPT-4, an advanced language model, in radiology. Giving the GPT-4 model prompts for generating reports, template generation, enhancing clinical decision-making, and suggesting captivating titles for research articles, patient communication, and education, can occasionally be quite generic, and at times, it may present factually incorrect content, which could lead to errors. The responses were then analyzed in detail regarding their potential utility in day-to-day radiologist workflow, patient education, and research processes. Further research is required to evaluate LLMs' accuracy and safety in clinical practice and to develop comprehensive guidelines for their implementation.
- 8 June 2023
- Published by Springer Nature in Cureus
- Vol. 15  (6) , e40135
Open AccessRadiology Gets Chatty: The ChatGPT Saga Unfolds
As artificial intelligence (AI) continues to evolve and mature, it is increasingly finding applications in the field of healthcare, particularly in specialties like radiology that are data-heavy and image-focused. Language learning models (LLMs) such as OpenAI's Generative Pre-trained Transformer-4 (GPT-4) are new in the field of medicine and there is a paucity of literature regarding the possible utilities of GPT-4 given its novelty. We aim to present an in-depth exploration of the role of GPT-4, an advanced language model, in radiology. Giving the GPT-4 model prompts for generating reports, template generation, enhancing clinical decision-making, and suggesting captivating titles for research articles, patient communication, and education, can occasionally be quite generic, and at times, it may present factually incorrect content, which could lead to errors. The responses were then analyzed in detail regarding their potential utility in day-to-day radiologist workflow, patient education, and research processes. Further research is required to evaluate LLMs' accuracy and safety in clinical practice and to develop comprehensive guidelines for their implementation.
- Open Access
- 30 April 2023
- Published by Springer Nature in Cureus
- Vol. 15  (4) , e38337
Foreign Body Reaction After Hip Augmentation Surgery: A Case Report
Hip augmentation cosmetic surgery is an increasingly popular procedure for patients seeking to enhance their body contour and improve their self-image. Despite its benefits, complications can arise, including the rare but serious foreign body reaction (FBR). We present a case of a 32-year-old patient with a history of hip augmentation cosmetic surgery who presented with persistent hip pain. A comprehensive clinical evaluation, followed by magnetic resonance imaging (MRI), revealed a foreign body reaction associated with the cosmetic augmentation procedure. This case report aims to describe the clinical presentation, diagnosis, and management of FBR in patients who have undergone hip augmentation cosmetic surgery. We will also discuss potential risk factors, prevention strategies, and the importance of early detection and intervention to avoid severe complications and improve patient outcomes. By sharing this case, we aim to raise awareness among healthcare professionals about this rare but significant complication of foreign body reaction and emphasize the need for close monitoring and timely intervention in patients who have undergone hip augmentation cosmetic surgery.
- 30 April 2023
- Published by Springer Nature in Cureus
- Vol. 15  (4) , e38337
Open AccessForeign Body Reaction After Hip Augmentation Surgery: A Case Report
Hip augmentation cosmetic surgery is an increasingly popular procedure for patients seeking to enhance their body contour and improve their self-image. Despite its benefits, complications can arise, including the rare but serious foreign body reaction (FBR). We present a case of a 32-year-old patient with a history of hip augmentation cosmetic surgery who presented with persistent hip pain. A comprehensive clinical evaluation, followed by magnetic resonance imaging (MRI), revealed a foreign body reaction associated with the cosmetic augmentation procedure. This case report aims to describe the clinical presentation, diagnosis, and management of FBR in patients who have undergone hip augmentation cosmetic surgery. We will also discuss potential risk factors, prevention strategies, and the importance of early detection and intervention to avoid severe complications and improve patient outcomes. By sharing this case, we aim to raise awareness among healthcare professionals about this rare but significant complication of foreign body reaction and emphasize the need for close monitoring and timely intervention in patients who have undergone hip augmentation cosmetic surgery.